AlphaYouEV
Insider selling
Eric Venker sold Roivant Sciences Ltd. (ROIV) stock
Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd. (ROIV), sold 200,000 shares of ROIV stock, per an SEC Form 4 filed Jun 26, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 24, 2026, 2 days before it was made public.
ROIV has moved +14.6% since the trade date, from $34.01 to $38.99 (Sep 21, 2026 close).
- Traded
- Jun 24, 2026
- Disclosed
- Jun 26, 2026
- Filing delay
- 2 days
- Price since
- +14.6%
- Role
- President & Immunovant CEO
- Source
- SEC Form 4
More ROIV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.